CARE Program 2007

Continuing Assessment, Review, and Evaluation Program

CARE 2006 Development Faculty

Allan C. Gelber, MD, Chair
Johns Hopkins University School of Medicine
Baltimore, MD

Ramon Arroyo, MD
Brooke Army Medical Center
San Antonio, TX

W. Winn Chatham, MD
University of Alabama-Birmingham
Birmingham, AL

Simon M. Helfgott, MD
Brigham & Women’s Hospital
Rheumatology & Immunology
Boston, MA

Kevin M. Latinis, MD, PhD
Kansas University Medical Center
Internal Medicine/Division of Rheumatology
Kansas City, KS

Alan Matsumoto, MD
Arthritis & Rheumatism Associates
Wheaton, MD

Robert A. Moidel, MD
Rheumatology Associates
Colmar, PA

Barry M. Schimmer, MD
Pennsylvania Rheumatology Associates
Philadelphia, PA

Contributor:
John J. Cush, MD
Baylor Research Institute
Dallas, TX

Conflict of Interest / Disclosure Statements

As an educational provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) it is the ACR’s policy to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
Research grants
Employment (full or part-time)
Ownership or partnership
Consulting fees or other remuneration (payment)
Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
Receipt of royalties
Speakers’ bureau
Other

Faculty disclosures listed apply in numeric format according to the list above. In accordance with ACR policy an individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for the development, management, presentation or evaluation of the CME activity.

The faculty reported the following disclosures:

Allan C. Gelber, MD –Nothing to disclose
Ramon Arroyo, MD – Abbott: 8
W. Winn Chatham, MD – Nothing to disclose
Simon M. Helfgott, MD – Teva Pharmaceuticals: 5, Abbott Immunology, Centocor, Genentech, Merck: 8
Kevin Latinis, MD, PhD – Abbott, Bristol-Myers Squibb, Centocor, and Genentech: 8; Genentech/Idec/Roche, Centocor, Human Genome Sciences, Pfizer, Schering-Plough: 9; Wyeth/ Amgen, Centocor, Abbott, Merck, Pfizer, Proctor and Gamble, Daiichi, Ortho-McNeil, TAP Pharmaceuticals, Bristol-Myers Squibb, Genentech: 5
Robert A. Moidel, MD –Abbott Laboratories:8, Bristol-Myers Squib, Genentech: 9
Alan Matsumoto, MD –Abbott, Genentech/Biogen, Pfizer: 8, Pfizer, Merck, Centocor, Genentech, Savient, Hoffman-La Roche, Eli Lilly:2
Barry M. Schimmer, MD – Abbott Immunology, Lilly, Pfizer, Tap Pharmaceuticals, Roche/Glaxo: 5,8